211 related articles for article (PubMed ID: 21502917)
1. Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
Chen C; Zhang Y; Wang Y; Huang D; Xi Y; Qi Y
Anticancer Drugs; 2011 Jun; 22(5):435-43. PubMed ID: 21502917
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC
Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421
[TBL] [Abstract][Full Text] [Related]
3. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Wang X; Wang G; Dong D; Fu S; Yang B
Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
[TBL] [Abstract][Full Text] [Related]
4. [Effects of 3'-azido-deoxythymidine on telomerase activity and protein expression of hepatocarcinoma cell line SMMC-7721].
He M; Jiang YY; Zhu M; Wei X; Qin J; Zhang ZY; Li L
Ai Zheng; 2006 May; 25(5):543-8. PubMed ID: 16687071
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Zhou C; Boggess JF; Bae-Jump V; Gehrig PA
Gynecol Oncol; 2007 Apr; 105(1):218-22. PubMed ID: 17275888
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
7. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
8. [The effect of As2O3 on induction of apoptosis and inhibition of telomerase activity in colon cancer LS-174T cells].
Wang XS; Wang GY; Xu HT; Wang K; Liu M; Fu SB; Geng JS; Zhang QF; Dong XS; Zhao JH
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):415-8. PubMed ID: 17974272
[TBL] [Abstract][Full Text] [Related]
9. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
Ma Y; Wang J; Liu L; Zhu H; Chen X; Pan S; Sun X; Jiang H
Cancer Lett; 2011 Feb; 301(1):75-84. PubMed ID: 21078540
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
[TBL] [Abstract][Full Text] [Related]
11. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts.
Shen ZY; Zhang Y; Chen JY; Chen MH; Shen J; Luo WH; Zeng Y
Oncol Rep; 2004 Jan; 11(1):155-9. PubMed ID: 14654919
[TBL] [Abstract][Full Text] [Related]
12. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
[TBL] [Abstract][Full Text] [Related]
13. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
[TBL] [Abstract][Full Text] [Related]
14. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
15. Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.
Seol JG; Park WH; Kim ES; Jung CW; Hyun JM; Lee YY; Kim BK
Int J Oncol; 2001 Feb; 18(2):249-55. PubMed ID: 11172589
[TBL] [Abstract][Full Text] [Related]
16. Preparation of arsenic trioxide-loaded albuminutes immuno-nanospheres and its specific killing effect on bladder cancer cell in vitro.
Zhou J; Zeng FQ; Li C; Tong QS; Gao X; Xie SS; Yu LZ
Chin Med J (Engl); 2005 Jan; 118(1):50-5. PubMed ID: 15642226
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
Moon Y; Park G; Kim Y; Kim M; Lim J; Pai SH; Lee EJ; Kang CS; Han K
Ann Clin Lab Sci; 2004; 34(3):271-6. PubMed ID: 15487701
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo.
Zhang T; Wang SS; Hong L; Wang XL; Qi QH
J Exp Clin Cancer Res; 2003 Mar; 22(1):61-8. PubMed ID: 12725324
[TBL] [Abstract][Full Text] [Related]
20. Effect of arsenic trioxide on multidrug resistant hepatocellular carcinoma cells.
Chan JY; Siu KP; Fung KP
Cancer Lett; 2006 May; 236(2):250-8. PubMed ID: 15982806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]